Prices, Profits, and Innovation: Examining Criticisms of New Psychotropic Drugs' Value

Health Affairs - United States
doi 10.1377/hlthaff.25.3.635
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Health Affairs (Project Hope)

Related search

Adverse Reactions to Psychotropic Drugs

The Lancet
Medicine
1967English

Psychotropic Drugs in Depot Form.

BMJ
1976English

Who Profits From Innovation in Global Value Chains? A Study of the iPod and Notebook PCs

SSRN Electronic Journal
2008English

Psychotropic Drugs and Electrocardiogram in Schizophrenic Patients

Japanese Journal of Clinical Pharmacology and Therapeutics
Pharmacology
1979English

Who Profits From Innovation in Global Value Chains?: A Study of the iPod and Notebook PCs

Industrial and Corporate Change
EconomicsEconometrics
2009English

Prescribing Psychotropic Drugs in General Practice

BMJ
1988English

Psychotropic Drugs: Implications for Dental Practice

Anesthesia Progress
AnesthesiologyPain Medicine
2008English

Examining the Relationship Between Value Propositions and Scaling Value for New Companies

Technology Innovation Management Review
2020English

The Present Value of Corporate Profits

IMF Working Papers
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy